Scientific Literature

September 8, 2020

Functions of p38 MAP Kinases in the Central Nervous System

Journal – Frontiers in Molecular Neuroscience. 13:570586, 2020.

Read More

July 31, 2020

P38α MAPK Signaling—A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease

International Journal of Molecular Sciences. 2020; 21(15): 5485.

Read More

May 29, 2018

Associations of MAP2K3 Gene Variants With Superior Memory in SuperAgers

Frontiers in Aging Neuroscience. Volume 10, Article 155, 2018.

Read More

December 6, 2017

Forecasting the Prevalence of Preclinical and Clinical Alzheimer’s Disease in the United States

Alzheimer’s & Dementia. Volume 14, Issue 2, 2018.

Read More

December 15, 2016

Selective Suppression of the α Isoform of p38 MAPK Rescues Late-Stage Tau Pathology

Alzheimer’s Research & Therapy. 8:54, 2016.

Read More

September 8, 2015

Synapse-Specific IL-1 Receptor Subunit Reconfiguration Augments Vulnerability to IL 1β in the Aged Hippocampus

Proceedings of the National Academy of Sciences of the United States of America. 2015.

Read More

About EIP

Are you a patient, caregiver, clinician or professional and want to learn more about EIP Pharma’s approach? Please contact us.

Contact Us